235 related articles for article (PubMed ID: 24799339)
1. In vitro effect of antibiotics on biofilm formation by Bacteroides fragilis group strains isolated from intestinal microbiota of dogs and their antimicrobial susceptibility.
Silva JO; Martins Reis AC; Quesada-Gómez C; Pinheiro AQ; Freire RS; Oriá RB; de Carvalho CB
Anaerobe; 2014 Aug; 28():24-8. PubMed ID: 24799339
[TBL] [Abstract][Full Text] [Related]
2. Development of EUCAST disk diffusion method for susceptibility testing of the Bacteroides fragilis group isolates.
Nagy E; Justesen US; Eitel Z; Urbán E;
Anaerobe; 2015 Feb; 31():65-71. PubMed ID: 25464140
[TBL] [Abstract][Full Text] [Related]
3. [ESBL-positive strains of the Bacteroides fragilis group isolated from patients at the regional hospital center in Płock (Poland)].
Rokosz A; Pawłowska J; Sawicka-Grzelak A; Luczak M
Med Dosw Mikrobiol; 2004; 56(3):245-53. PubMed ID: 15773501
[TBL] [Abstract][Full Text] [Related]
4. [Bacteroides fragilis group in non-diarrheal human feces and its antimicrobial susceptibility].
Rodríguez E; Gamboa MM; Rodríguez C; Vargas P
Rev Esp Quimioter; 2006 Dec; 19(4):357-62. PubMed ID: 17235405
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of anaerobic bacteria to five antimicrobial agents and demonstration of resistance of Bacteroides fragilis to clindamycin.
Sofianou D; Douboyas J; Papapanagiotou J; Paradelis AG
Methods Find Exp Clin Pharmacol; 1982; 4(3):173-7. PubMed ID: 7121128
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of antimicrobial resistance patterns of enterotoxin gene positive and negative Bacteroides fragilis isolates].
Toprak NU; Yağci A; Celik C; Cakici O; Söyletir G
Mikrobiyol Bul; 2005 Apr; 39(2):145-52. PubMed ID: 16128024
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility trends of Bacteroides fragilis group and characterisation of carbapenemase-producing strains by automated REP-PCR and MALDI TOF.
Treviño M; Areses P; Peñalver MD; Cortizo S; Pardo F; del Molino ML; García-Riestra C; Hernández M; Llovo J; Regueiro BJ
Anaerobe; 2012 Feb; 18(1):37-43. PubMed ID: 22261518
[TBL] [Abstract][Full Text] [Related]
8. [Susceptibility to antimicrobial drugs of enterotoxin producing strains of Bacteroides fragilis isolated from different countries].
Obuch-Woszczatyński P; Rokosz A; Sawicka-Grzelak A; Pituch H; Meisel-Mikołajczyk F; Łuczak M
Med Dosw Mikrobiol; 2002; 54(3):253-8. PubMed ID: 12632660
[TBL] [Abstract][Full Text] [Related]
9. Resistance trends of Bacteroides fragilis group over an 8-year period, 1997-2004, in Korea.
Roh KH; Kim S; Kim CK; Yum JH; Kim MS; Yong D; Lee K; Kim JM; Chong Y
Korean J Lab Med; 2009 Aug; 29(4):293-8. PubMed ID: 19726890
[TBL] [Abstract][Full Text] [Related]
10. Virulence factors and biofilm production by isolates of Bacteroides fragilis recovered from dog intestinal tracts.
Reis AC; Silva JO; Laranjeira BJ; Pinheiro AQ; Carvalho CB
Braz J Microbiol; 2014; 45(2):647-50. PubMed ID: 25242953
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina.
Fernández Canigia L; Castello L; Di Martino A; Greco G; Legaria MC; Litterio M; Predari SC; Rollet R; Rossetti A; Carloni G; Sarchi MI; Bianchini H
Rev Argent Microbiol; 2007; 39(3):156-60. PubMed ID: 17987852
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial resistance in the Bacteroides fragilis group in faecal samples from patients receiving broad-spectrum antibiotics.
Hansen KCM; Schwensen SAF; Henriksen DP; Justesen US; Sydenham TV
Anaerobe; 2017 Oct; 47():79-85. PubMed ID: 28445776
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and antimicrobial resistance of B. fragilis group organisms isolated from clinical specimen and human intestinal microbiota.
de Carvalho CB; Moreira JL; Ferreira MC
Rev Inst Med Trop Sao Paulo; 1996; 38(5):329-35. PubMed ID: 9293074
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibilities of Bacteroides fragilis and Bacteroides thetaiotaomicron strains isolated from clinical specimens and human intestinal microbiota.
Ulger Toprak N; Celik C; Cakici O; Soyletir G
Anaerobe; 2004 Oct; 10(5):255-9. PubMed ID: 16701525
[TBL] [Abstract][Full Text] [Related]
15. Determinants of resistance in Bacteroides fragilis strains according to recent Brazilian profiles of antimicrobial susceptibility.
Paula GR; Falcão LS; Antunes EN; Avelar KE; Reis FN; Maluhy MA; Ferreira MC; Domingues RM
Int J Antimicrob Agents; 2004 Jul; 24(1):53-8. PubMed ID: 15225862
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility of anaerobic bacteria in Sweden in 1983.
Nord CE; Olsson-Liljequist B
Scand J Infect Dis Suppl; 1984; 43():44-9. PubMed ID: 6100139
[TBL] [Abstract][Full Text] [Related]
17. National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004.
Snydman DR; Jacobus NV; McDermott LA; Ruthazer R; Golan Y; Goldstein EJ; Finegold SM; Harrell LJ; Hecht DW; Jenkins SG; Pierson C; Venezia R; Yu V; Rihs J; Gorbach SL
Antimicrob Agents Chemother; 2007 May; 51(5):1649-55. PubMed ID: 17283189
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility to five antimicrobial agents of strains of the Bacteroides fragilis group isolated in Brazil.
De Almeida AE; De Uzeda M
Antimicrob Agents Chemother; 1987 Apr; 31(4):617-8. PubMed ID: 3649203
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of antimicrobial activity of amoxicillin/clavulanic acid and metronidazole against beta-lactamase-producing Bacteroides fragilis group.
García-Rodríguez JA; García Sánchez JE; Trujillano I; Muñoz-Bellido JL
J Chemother; 1990 Feb; 2(1):11-6. PubMed ID: 2332779
[TBL] [Abstract][Full Text] [Related]
20. Susceptibilities of species of the Bacteroides fragilis group to 10 antimicrobial agents.
Betriu C; Campos E; Cabronero C; Rodriguez-Avial C; Picazo JJ
Antimicrob Agents Chemother; 1990 Apr; 34(4):671-3. PubMed ID: 2344174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]